跳至主要内容
临床试验/JPRN-jRCT1092220172
JPRN-jRCT1092220172已完成3 期

Efficacy and safety of CP stent implantation for pulmonary stenosis associated with congenital heart diseases

Hideshi Tomita0 个研究点目标入组 25 人开始时间: 2014年3月26日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

Efficacy and safety of CP stent implantation using BIB and Z-MED II balloon was demonstrated by our clinical trial for pulmonary stenosis associated with congenital heart diseases.

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 <= 40age old(—)
性别
All

入选标准

  • Those who have one or two lesions of post-operative pulmonary stenosis including those of post-fenestrated Fontan operation, and have a history of ineffective PTA for the lesion within one year of enrollment, or PTA for the lesion will not be effective. Candidates must meet following 1) or 2) criteria.
  • 1)After Bi-ventricle repair; Either one of following (1)-(3)
  • (1)Elevation of RVp associated with PS Systolic RVp/ Systolic ascending AOp > 0.7
  • (2)Systolic pressure gradient through the stenosis>20 mmHg
  • (3)Stenosis ratio(1-MLD/ Ref vessel diameter)> 0.5
  • 2)After Uni-ventricular repair; Either one of following(1)-(3)
  • (1)Mean pressure gradient through the stenosis>3 mmHg
  • (2)Stenosis ratio(1-MLD/ Ref vessel diameter)>0.5
  • (3)Morphologically definite stenosis complicated by SaO2<85%

排除标准

  • (1)Previously implanted stent in the target lesion
  • (2)Contraindication for anti-coagulation or anti-platelet therapy
  • (3)Hemorrhagic diathesis or Hyper-coagulation state
  • (4)Active infection including endocarditis
  • (5)Serious Liver and/or Kidney damage
  • (6)Enrolled in the other clinical trials

研究者

发起方
Hideshi Tomita

相似试验